Categories Analysis, Finance

Can restructuring accelerate Citigroup’s recovery from slowdown?

The focus of management's strategy is to move resources to high-returning businesses and away from underperforming areas

The COVID vaccination campaign and the upbeat stock market, which witnessed a rally as many industries thrived on the virus-driven business boom, have added to the recovery hopes of the financial service sector. Citigroup Inc. (NYSE: C), which has embarked on a restructuring program under new chief Jane Fraser, is probably entering a period of sustained growth after navigating the crisis.

A Buying Opportunty?

It is estimated that the bank’s stock market performance would improve in the coming months, despite the concerns surrounding its lackluster revenue performance. It is worth noting that the stock has recouped most of the COVID-induced losses in recent months. While the majority of analysts following Citi see a buying opportunity, others have adopted a cautious stance citing the continuing macroeconomic uncertainty. Their average price target is $83.31, which is up around 15%.


Read management/analysts’ comments on Citigroup’s Q1 report


Fraser, who is the first woman to head a Wall Street bank, has an important task at hand – to lead the company’s recovery from the pandemic and regain investors’ confidence. Under her regime, the bank resumed its share buyback program, after enhancing the capital position. In a strategic move, the management has decided to exit more than a dozen consumer banking markets, including China, to focus more on the wealth management business. Currently, the focus of the growth strategy is on moving resources to high-returning businesses and away from underperforming areas.

Citigroup Q1 2021 earnings infographic

Strain on Revenue

Net profit, on a per-share basis, grew more than two-fold to $3.62 in the first quarter of 2021 and topped the Street view. Earnings got a boost from the release of loan loss reserves of about $3.9 billion. Meanwhile, revenues of the main operating divisions – global consumer banking and institutional clients group – dropped, resulting in a 7% decline in total revenues to $19.3 billion. Though the bottom-line experienced weakness during the crisis period, it stayed above the estimates consistently.

From Citigroup’s Q1 2021 earnings conference call:

“The bigger impact on loans is from the high payment rates. This is creating revenue pressure, but it’s also benefiting our delinquency and loss trends. So the good news is that we’re seeing the recovery in spend, which should continue, and our credit portfolio is proving to be quite resilient. We are now focused on loan and revenue recovery through driving spend activity, reentering the market for new account acquisitions, and investing in lending capabilities and new value propositions.”

Stock Performance

In a sign that the mixed first quarter outcome did not go well with investors, Citi’s stock began Thursday’s regular trading on a low note and maintained the downtrend throughout the session. In the past twelve months, the stock moved up 58% and is currently trading close to the pre-pandemic levels.

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

Kraft Heinz reports Q2 earnings: Infographic

The Kraft Heinz Company (NASDAQ: KHC) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The food company reported Q2 revenue of $6.62 billion, down 0.5% year-over-year

GM Earnings: Key quarterly highlights from General Motors Q2 financial results

General Motors Co. (NYSE: GM) reported second quarter 2021 earnings results today. Total revenue rose to $34.2 billion from $16.8 billion in the same period last year. GAAP net income

CVS Health Corp. (CVS) Earnings: 2Q21 Key Numbers

VS Health Corporation (NYSE: CVS) reported second-quarter 2021 earnings results today. Total revenues increased 11.1% to $72.6 billion compared to the same period last year, driven by growth across all

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top